SWM
MRNA icon

SeaCrest Wealth Management’s Moderna MRNA Stock Holding History

SeaCrest Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222K Buy
+3,174
New +$164K 0.02% 499
2025
Q1 		– Sell
-5,778
Closed -$240K – 683
2024
Q4 		$240K Sell
5,778
-213
-4% -$10.2K 0.03% 564
2024
Q3 		$400K Sell
5,991
-633
-10% -$58.1K 0.04% 401
2024
Q2 		$787K Buy
6,624
+7
+0.1% +$886 0.09% 215
2024
Q1 		$705K Sell
6,617
-352
-5% -$35.5K 0.09% 241
2023
Q4 		$774K Buy
6,969
+1,993
+40% +$168K 0.1% 222
2023
Q3 		$514K Sell
4,976
-268
-5% -$29.9K 0.07% 298
2023
Q2 		$637K Sell
5,244
-1,320
-20% -$176K 0.08% 259
2023
Q1 		$1.01M Sell
6,564
-135
-2% -$22.3K 0.14% 160
2022
Q4 		$1.2M Sell
6,699
-247
-4% -$40.4K 0.17% 133
2022
Q3 		$821K Sell
6,946
-2,787
-29% -$423K 0.12% 181
2022
Q2 		$1.39M Buy
9,733
+435
+5% +$62.2K 0.18% 112
2022
Q1 		$1.6M Sell
9,298
-652
-7% -$110K 0.18% 114
2021
Q4 		$2.53M Buy
9,950
+1,123
+13% +$328K 0.28% 65
2021
Q3 		$3.4M Buy
8,827
+1,123
+15% +$414K 0.41% 48
2021
Q2 		$1.81M Buy
7,704
+978
+15% +$175K 0.22% 94
2021
Q1 		$881K Sell
6,726
-519
-7% -$75.2K 0.12% 193
2020
Q4 		$757K Sell
7,245
-2,617
-27% -$265K 0.11% 214
2020
Q3 		$698K Sell
9,862
-3,794
-28% -$265K 0.11% 201
2020
Q2 		$877K Buy
+13,656
New +$748K 0.15% 151
2019
Q2 		– Sell
-200
Closed -$4K – 1327
2019
Q1 		$4K Sell
200
-100
-33% -$1.86K ﹤0.01% 1790
2018
Q4 		$5K Buy
+300
New +$4.93K ﹤0.01% 1704

Other funds holding MRNA

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
LAI
Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

SeaCrest Wealth Management's MRNA Position: Q2 2026 in Review

SeaCrest Wealth Management opened a new position in Moderna (MRNA) in Q2 2026: 3,174 shares worth $222K. The stake represents 0.02% of the portfolio and ranks #499 among its holdings. This is a return to the name: SeaCrest Wealth Management previously reported a position in MRNA as recently as Q4 2024.

SeaCrest Wealth Management first reported a position in MRNA in Q4 2018 and has held it in 22 quarters since. The position peaked at $3.4M in Q3 2021. 108 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • SeaCrest Wealth Management held 3,174 shares of Moderna worth $222K as of Q2 2026.
  • Moderna was a new SeaCrest Wealth Management position in Q2 2026.
  • Moderna made up 0.02% of SeaCrest Wealth Management's portfolio in Q2 2026, its #499 holding.
  • SeaCrest Wealth Management first reported a position in Moderna in Q4 2018 and has held it in 22 quarters since.
  • SeaCrest Wealth Management's Moderna position peaked at $3.4M in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.